Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Sarcopenia Treatment Industry By 2029?
The market for sarcopenia treatments has seen significant expansion in the last few years. The market size is projected to increase from $3.52 billion in 2024 to $3.72 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.8%. This impressive growth throughout the historical period is a result of a range of factors, including an aging demographic, heightened awareness and diagnosis, changes in lifestyle, public health campaigns, and regulatory approvals.
Strong expansion is projected for the sarcopenia treatment market in the upcoming years, with it anticipated to reach $4.69 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.0%. Factors such as personalized medicine, nutritional interventions, digital health platforms, patient education and empowerment, and global health initiatives account for this growth during the forecast period. Notable trends within this period include the presence of personalized therapies, the introduction of new drug classes, the incorporation of digital health, cooperative research projects, and research and development.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp
Which Industry Forces Are Driving The Sarcopenia Treatment Market Forward?
The escalating rates of malnutrition are predicted to spur the expansion of the sarcopenia treatment market. Malnutrition comprises both surpluses and deficits or unequal distribution in an individual’s consumption of energy and nutrients, encompassing undernutrition, obesity, and diet-related noncommunicable diseases. Sarcopenia treatment can alleviate the concurrent issues of malnutrition and sarcopenia found in older individuals via strategies such as exercise and nutritional therapy, with the aim of augmenting muscle mass, strength, and overall nutritional health. For example, per a report from the World Health Organization (WHO), a UN organization located in Switzerland, published in December 2023, malnutrition continues to be a major global health problem, with an estimated 462 million individuals underweight and 149 million children under five showing signs of stunted growth in 2022. Thus, the increasing rates of malnutrition are propelling the sarcopenia treatment market’s growth.
What Is The Segment Breakdown Of The Sarcopenia Treatment Market?
The sarcopenia treatmentmarket covered in this report is segmented –
1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
2) By Type: Primary Sarcopenia; Secondary Sarcopenia
3) By Route Of Administration: Oral; Parenteral; Enteral
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Protein Supplements: Whey Protein; Casein Protein; Soy Protein; Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin; Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2; Vitamin D3; Calcium Carbonate; Calcium Citrate
4) By Other Treatment Types: Exercise Programs; Hormone Replacement Therapy; Other Nutritional Interventions
What Are The Dominant Trends Currently Seen In The Sarcopenia Treatment Market?
Prominent businesses active in the sarcopenia treatment market are directing their efforts towards the progression of various advanced clinical study solutions to provide superior treatment options. A clinical study refers to a methodical investigation carried out on human subjects to assess the safety, effectiveness and potential outcomes of a medical procedure. For example, Biophytis, a biotech firm located in France, received authorization from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 study into sarcopenia in September 2023. The goal of this research is to assess the effectiveness and safety of Sarconeos (BIO101) in treating sarcopenic patients at risk of losing motor function. This research indicates a substantial progression in tech-based and pharmaceutical treatment methods, posing potential efficacy and safety advantages for patients with severe sarcopenia. This is the inaugural phase 3 study into sarcopenia that is FDA-approved. Approximately 900 patients over the age of 65, suffering from sarcopenia, reduced walking speed, and low hand grip strength, will be included in the study. The primary objective will be to evaluate factors such as the risk of major mobility disability (MMD), walking speed, hand grip strength, and the patient’s perceived quality of life.
Which Companies Are Contributing Significantly To The Sarcopenia Treatment Market Growth?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report
Which Region Is Leading Innovation In The Sarcopenia Treatment Market?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp
Browse Through More Reports Similar to the Global Sarcopenia Treatment Market 2025, By The Business Research Company
Reversible Airway Diseases Treatment Global Market Report 2025
Urothelial Carcinoma Treatment Global Market Report 2025
Mineral And Bone Disorder Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
